Literature DB >> 19043688

[Epidemiology and etiology of therapy-resistant hypertension].

C Schirpenbach1, M Reincke.   

Abstract

Uncontrolled arterial hypertension is a frequent clinical problem, affecting 1/10 of hypertensive subjects, and can lead to severe renal, cerebral and cardiovascular damage. Common causes of poorly controlled blood pressure include lack of compliance, inadequate antihypertensive medication and white-coat hypertension, all referred to as "false" therapy-resistant hypertension. 4-19% of patients with arterial hypertension suffer from "true" therapy-resistant hypertension: this is defined as failure to achieve target blood pressure values despite full-dose triple drug regimen including a diuretic. In most cases, its etiology is multifactorial. Frequent causes include interfering medication, volume overload, chronic kidney disease, obstructive sleep apnea and secondary causes such as primary aldosteronism. Factors such as obesity, high salt intake and excessive alcohol ingestion contribute to poor blood pressure control. This article reviews the literature and describes epidemiology and etiology of therapy-resistant hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19043688     DOI: 10.1007/s00108-008-2194-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  30 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.

Authors:  Mari K Nishizaka; Monique Pratt-Ubunama; Mohammad A Zaman; Stacey Cofield; David A Calhoun
Journal:  Am J Hypertens       Date:  2005-06       Impact factor: 2.689

3.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

Authors:  Stella Douma; Konstantinos Petidis; Michael Doumas; Panagiota Papaefthimiou; Areti Triantafyllou; Niki Kartali; Nikolaos Papadopoulos; Konstantinos Vogiatzis; Chrysanthos Zamboulis
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

4.  Resistant hypertension revisited: a comparison of two university-based cohorts.

Authors:  Jay P Garg; William J Elliott; Amy Folker; Munavvar Izhar; Henry R Black
Journal:  Am J Hypertens       Date:  2005-05       Impact factor: 2.689

5.  White-coat resistant hypertension.

Authors:  A Mezzetti; S D Pierdomenico; F Costantini; F Romano; A Bucci; M Di Gioacchino; F Cuccurullo
Journal:  Am J Hypertens       Date:  1997-11       Impact factor: 2.689

6.  Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

Authors:  Monique N Pratt-Ubunama; Mari K Nishizaka; Robyn L Boedefeld; Stacey S Cofield; Susan M Harding; David A Calhoun
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

7.  Is resistant hypertension really resistant?

Authors:  M A Brown; M L Buddle; A Martin
Journal:  Am J Hypertens       Date:  2001-12       Impact factor: 2.689

8.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

9.  High prevalence of secondary hypertension and insulin resistance in patients with refractory hypertension.

Authors:  Nieves Martell; Matilde Rodriguez-Cerrillo; D E Grobbee; M Dolores López-Eady; Carmen Fernández-Pinilla; Mario Avila; Arturo Fernández-Cruz; Manuel Luque
Journal:  Blood Press       Date:  2003       Impact factor: 2.835

10.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  3 in total

Review 1.  [Cardiac sequelae of hypertension].

Authors:  M Steinmetz; G Nickenig
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

2.  Determinants of uncontrolled hypertension among clients on anti-retroviral therapy in Kadoma City, Zimbabwe, 2016.

Authors:  Pamela Nyaradzai Magande; Daniel Chirundu; Notion Tafara Gombe; More Mungati; Mufuta Tshimanga
Journal:  Clin Hypertens       Date:  2017-07-04

3.  Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism.

Authors:  Lukas Engler; Christian Adolf; Daniel A Heinrich; Anna-Katharine Brem; Anna Riester; Anna Franke; Felix Beuschlein; Martin Reincke; Axel Steiger; Heike Künzel
Journal:  Endocr Connect       Date:  2019-04       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.